Venus Remedies Limited Docetaxel Export Data — India (DGFT 2022–2026)

Name: Venus Remedies Limited Docetaxel Export Records India — #10 Exporter, 97 Shipments, $829.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Docetaxel

India Pharmaceutical Trade Intelligence

$39.6M253 Suppliers120 CountriesHS 30049044

ExportsIndia → UNITED STATES26.6%India → AFGHANISTAN10.1%

ImportsGERMANY → India$266.0K SINGAPORE → India$165.7K

#1 Supplier: FRESENIUS KABI #1 Buyer: MYLAN INSTITUTIONAL

Venus Remedies Limited — Docetaxel Exporter #10 | $829.1K Trade Value | TransData Nexus | TransData Nexus

Venus Remedies Limited — Docetaxel Exporter Profile

Indian Pharmaceutical Exporter · #10 for Docetaxel · $829.1K export value · DGFT Verified

Venus Remedies Limited is the #10 Indian exporter of Docetaxel with $829.1K in export value and 97 verified shipments. Venus Remedies Limited holds a 2.1% market share in Docetaxel exports across 16 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.

Venus Remedies Limited — Docetaxel Export Profile: Buyers & Destinations

Venus Remedies Limited Docetaxel export treemap — buyers and destination countries | TransData Nexus

Where Does Venus Remedies Limited Export Docetaxel?

Country	Value	Shipments	Share
TANZANIA	$127.3K	9	16.2%
COLOMBIA	$107.3K	7	13.6%
IRAQ	$97.0K	5	12.3%
INDONESIA	$93.0K	9	11.8%
BOTSWANA	$84.7K	12

Who Are the Top Buyers of Docetaxel from Venus Remedies Limited?

Buyer	Country	Value	Orders
KIMADIA	IRAQ	$97.0K	5
H H B S	COLOMBIA	$68.7K	4
P V L	BOTSWANA	$59.6K	7
K P L	TANZANIA	$52.5K	2
NATPHARM CO	ZIMBABWE	$50.0K	1
PT M L	INDONESIA	$47.4K	3
KASTI PHARM LIMITED	TANZANIA	$40.7K	3
PT MEGA LIFESCIENCES INDONESIA	INDONESIA	$40.0K	5
H L	KENYA	$34.8K	8
NI LAY NAING CO.,LTD	MYANMAR	$29.2K	6

Venus Remedies Limited supplies Docetaxel to 49 buyers globally. The largest buyer is KIMADIA (IRAQ), followed by H H B S (COLOMBIA) and P V L (BOTSWANA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Docetaxel Formulations Does Venus Remedies Limited Export?

Product Description / Formulation	Value	Shipments
DOCETAXEL INJECTION CONCENTRATE (80 MG/2	$59.2K	5
DOCETAXEL INJ. CONCENTRATE (80 MG/2.0 ML	$50.0K	1
DOCETAXEL INJ CONCENTRATE (80MG/2.0 ML)	$50.0K	1
DOCETAXEL INJ. CONCENTRATE (120 MG/3.0 ML)DOXOL 120 MG.B.NO. X4CDO043A,X4CDO033AMFG. DT. 03/2024 , EXP. DT. 02/2026	$50.0K	1
DOCETAXEL 80MG/2 ML CONCENTRATE FOR SOLUTION FOR INFUSION (DOCETAXEL 80 MG)	$44.9K	2
DOCETAXEL INJECTION CONCENTRATE 80 MG/2	$31.4K	3
DOCETAXEL INJECTION CONCENTRATE (20 MG/0	$31.2K	4
DOCETAXEL INJECTION CONCENTRATE (80 MG/2.0 ML) (DOXOMED 80MG)	$24.3K	1
DOCETAXEL INJECTION CONCENTRATE 80 MG/2.	$23.4K	1
DOXOL DOCETAXEL CONCENTRATE FOR SOLUTIO	$17.2K	2

Venus Remedies Limited exports 78 distinct Docetaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOCETAXEL INJECTION CONCENTRATE (80 MG/2 with 5 shipments worth $59.2K.

How Does Venus Remedies Limited Compare to Nearest Docetaxel Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	NV REMEDIES PRIVATE LIMITED	$959.1K	27	4	$35.5K
3	KWALITY PHARMACEUTICALS LIMITED	$900.0K	18	10	$50.0K
10	VENUS REMEDIES LIMITED ★	$829.1K	97	16	$8.5K
11	VEXXA LIFESCIENCES PVT. LTD.	$817.5K	64	2	$12.8K
5	JODAS EXPOIM PRIVATE LIMITED	$700.0K	14	1	$50.0K

Venus Remedies Limited ranks #10 among 253 Indian Docetaxel exporters. Average shipment value of $8.5K compared to the market average of $88.6K. The closest competitors by value are NV REMEDIES PRIVATE LIMITED and KWALITY PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Docetaxel Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	530	20.1%
DELHI AIR	416	15.8%
SAHAR AIR CARGO ACC (INBOM4)	379	14.4%
SAHAR AIR	372	14.1%
Bombay Air	132	5.0%
Delhi Air	90	3.4%
HYDERABAD AIR	79	3.0%
HYDERABAD ACC (INHYD4)	54	2.1%

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Docetaxel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)

Venus Remedies Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)

These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Docetaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 100 individual customs records matching Venus Remedies Limited exporting Docetaxel, covering 78 formulations to 17 countries via 49 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 120+ countries, 641+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Docetaxel

Docetaxel

Venus Remedies Limited — Docetaxel Exporter Profile

Venus Remedies Limited — Docetaxel Export Profile: Buyers & Destinations

Where Does Venus Remedies Limited Export Docetaxel?

Who Are the Top Buyers of Docetaxel from Venus Remedies Limited?

What Is India's Total Docetaxel Export Value and How Much Does Venus Remedies Limited Contribute?

What Is the Average Shipment Value for Venus Remedies Limited's Docetaxel Exports?

How Does Venus Remedies Limited Compare to Other Indian Docetaxel Exporters?

What Docetaxel Formulations Does Venus Remedies Limited Export?

How Does Venus Remedies Limited Compare to Nearest Docetaxel Exporters?

Which Indian Ports Ship Docetaxel Exports?

What Other Oncology Products Does Venus Remedies Limited Export?

Geopolitical & Trade Policy Impact on Venus Remedies Limited's Docetaxel Exports

Venus Remedies Limited — Regulatory Compliance & Quality Standards

About Venus Remedies Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Docetaxel Export Data from Venus Remedies Limited

Docetaxel Stats

Company Overview

Top Products by Venus Remedies Limited

Related Analysis

Need Detailed Export Data?

Data Source